Pseudotumor cerebri is a syndrome disorder defined
clinically by four criteria: (1) elevated intracranial
pressure as demonstrated by lumbar puncture; (2) normal
cerebral anatomy, as demonstrated by neuroradiographic
evaluation; (3) normal cerebrospinal fluid composition;
and (4) signs and symptoms of increased intracranial
pressure, including papilledema. While the mechanism
of PTC is not fully understood, most experts agree
that the disorder results from poor absorption of
cerebrospinal fluid by the meninges surrounding the
brain and spinal cord. The subsequent increase in
extracerebral fluid volume leads to elevated intracranial
pressure. However, because the process is slow and
insidious, there is ample time for the ventricular
system to compensate and this explains why there is
no dilation of the cerebral ventricles in PTC. Increased
intracranial pressure induces stress on the peripheral
aspects of the brain, including the cranial nerves.
Stagnation of axoplasmic flow in the optic nerve (CN
II) results in papilledema and transient visual obscurations;
when the abducens nerve (CN VI) is involved, the result
is intermittent nerve palsy and diplopia. Many conditions
and factors have been proposed as causative agents
of PTC, including excessive dosages of some exogenously
administered medications (e.g., vitamin A, tetracycline,
minocycline, naladixic acid, corticosteroids), endocrinologic
abnormalities, anemias, blood dyscrasias, and chronic
respiratory insufficiency. However the majority of
cases remain idiopathic in nature.
Management
All patients presenting with suspected papilledema
or other manifestations of intracranial hypertension
warrant prompt medical evaluation and neurologic testing.
Current protocol dictates that patients presumptively
diagnosed with papilledema must undergo neuroimaging
via computed tomography or, preferably, magnetic resonance
imaging within 24 hours. These tests are meant to
rule out space-occupying intracranial mass lesions,
and therefore should be ordered with contrast media
unless otherwise contraindicated. In cases of PTC,
neuroimaging typically displays small to normal-sized
cerebral ventricles with otherwise normal brain structure.
Patients with unremarkable radiographic studies should
be subsequently referred for neurosurgical consultation
and lumbar puncture. (Lumbar puncture should not be
ordered until neuroimaging is found negative for space-occupying
mass due to risk for herniation of brainstem through
foramen magnum secondary to mass during lumbar puncture.)
Additional medical testing includes serologic and
hematologic studies. Therapy for patients with PTC
varies, but in most instances initiate systemic medications
as a first line treatment. Typically, the drug of
choice for the initial management of PTC is oral acetazolamide
(Diamox), although other diuretics including chlorthalidone
(Hygroton) and furosemide (Lasix) may also be used
effectively. Corticosteroid therapy is considered
controversial in the management of PTC. While a short-term
course of oral or intravenous dexamethasone may be
helpful in initially lowering intracranial pressure,
it is not considered to be an effective long-term
therapy because of the potential for systemic and
ocular complications. For patients in whom conventional
medical therapy fails to alleviate the symptoms and
prevent pathologic decline, surgical intervention
is the only definitive treatment. Cerebrospinal fluid
shunting procedures are commonly employed in recalcitrant
cases of PTC, but are successful in only 70 to 80
percent of cases. Optic nerve sheath decompression
has also been advocated as a method to alleviate chronic
disc edema, although this technique fails to directly
address the issue of elevated intracranial pressure.
It also demonstrates a particularly high failure rate.
Optometric management of patients diagnosed with PTC
includes careful and frequent evaluation, including
threshold visual fields, acuity measurement, contrast
sensitivity, and indirect ophthalmoscopy. Photodocu-mentation
of the nerve heads should also be performed.